| Tag | Content |
|---|
EnhancerAtlas ID | HS105-36669 | Organism | Homo sapiens | Tissue/cell | IMR90 | Coordinate | chr18:9433450-9434730 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_30791 | chr18:9432975-9435510 | Fetal_Muscle |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH18I009433 | chr18 | 9433030 | 9435784 |
| Enhancer Sequence | ATGTAATGCA TGCTTGATTC CCCTTCACCT TCCACCATGA TTGTAAGTTT CCTGAGGCCT 60
CCCCAGCCAT GCCTCCTGTA CAGCCTGCAG AACCATGAGC CAGTTAAACC TCTTTTCTCT 120
ATAAATCACC CAGTCTCCAG TAACAGTGCA AGAACGGACT AATACAATGT ATTTATTTGA 180
AGTGCTTCTG AAGACGAACT GCCTCTAAAC TTCACTATCT GGGGCACAAA CATCAGCAAG 240
CTGGAGAACG CCCTTGGCCT GCTGCAGCTC CCTTGACATC GTCTTGCATT ACTTCCTCCG 300
GTGGCCTCAC TCCAGAGACT ACCCCTGGTC CGTGAAAAGC AGAAGGCAAA TGAAAATGTA 360
TACGTTGTAA ACCCACGACT CATTTCAGCC AGCCAGGCAT CTCTTTCCCT TTTATCATTA 420
CACAAGTAAA GCATGAATTC ATGCTGATTG TAAAAAAAAT GCAGCAAGGC AGAAATACAT 480
GGAGCAAAAA GTGAAAGCCC CTTCATCACA CCTTCTTTCC ATCTGCTTCC CCTCCCAGAC 540
GTCTCTCAGA GTATTTATAG ATTCAACAGA TGGAAGACCT CCCGCCCCAG CTCGGCTCCA 600
CCCCACCCCG GCTCCACCCC ACCCCTGCAC TCCTAGGAAG ACCTCTCCTC CTCACTCCCC 660
AAGAGCACAG ATTTTATGCT GGAGAATTTC TGGAGTGGAA AAGGAGGCCC AGTTTTACAA 720
ACTAAAGGGG TCCCATAGAT ACCTCAGGAA GAGAGGGAAA GCCAAGCACG AGTCTGTAGA 780
GGGGGAGGGG GCAGCCTGGG GGCAGCCTAG CGACAGGCGG CCGGCGGGCA AGCAGAGAGG 840
CTGCAGGCAG TCAGCTTTGG GGACAGTGAG GAGGCTGTGA GTTGCTCAGA CAGAGGCAGG 900
GGCACACAGA GGCCTCCCTC CCAGGGAACA GCTCCAGCTT TAGGACCCAT CTTTTGCAGC 960
TCAGGAGCCG TTCTGAGTTA GCAAGGACGT GTACCCTTCT AAGCCTTCCT TTGTTTCTTT 1020
GTGTAACTGC CTTTGTCTGG GGAGCCCCGG GGGCTGCAGC GGTCAGGAGG AAGCGGGCCC 1080
AGCCTCAGCC AGGCCTGCAC GGCGGAGGGG CAGCCCCACT CTCCGGAAAC AGGGAGGGCC 1140
CAGCGCAGAG CAGCGTTCCC CAGCAGAGCA CAGTGAGATG GGCCTGGGCC TGCCTTTGGG 1200
GTGGGAAGAA GCTGCCCTTA AAAAGGGGTT ACAGGCCGGG CGCGGTGGCC CACACCTGTA 1260
ATCACAGCAC TTTGGGAGGC 1280
|
| |
|
|
|
